Current management of esophageal squamous-cell carcinoma in Japan and other countries. - Wikidata - awgldk - TriplyDB

Current management of esophageal squamous-cell carcinoma in Japan and other countries.

Current management of esophageal squamous-cell carcinoma in Japan and other countries.

http://www.wikidata.org/entity/Q42113341

about

Involved-field radiotherapy for esophageal squamous cell carcinoma: theory and practice A Retrospective Comparison of Taxane and Fluorouracil-based Chemoradiotherapy in Patients with Inoperable Esophageal Squamous Cell Carcinoma.Capilliposide C Sensitizes Esophageal Squamous Carcinoma Cells to Oxaliplatin by Inducing Apoptosis Through the PI3K/Akt/mTOR Pathway.Current management of esophageal cancer Luteolin inhibits cell proliferation and induces cell apoptosis via down-regulation of mitochondrial membrane potential in esophageal carcinoma cells EC1 and KYSE450.GALNT14 genotype as a response predictor for concurrent chemoradiotherapy in advanced esophageal squamous cell carcinoma.Relationship between TLR4 and NF-κB p65 protein expressions and clinical radiosensitivity of patients with esophageal squamous cell carcinoma.The role of HGF/MET and FGF/FGFR in fibroblast-derived growth stimulation and lapatinib-resistance of esophageal squamous cell carcinoma.Salvage esophagectomy under bilateral thoracotomy after definitive chemoradiotherapy for aorta T4 thoracic esophageal squamous cell carcinoma: Report of a case.Prognostic Nomogram for Thoracic Esophageal Squamous Cell Carcinoma after Radical Esophagectomy.Multidisciplinary therapy for granulocyte-colony-stimulating factor producing carcinosarcoma of the esophagus: report of a case.Multidetector-computed tomography attenuation values between the tumor and aortic wall in response to induction therapy for esophageal cancer and its predictive value for aortic invasion Prognosis was not deteriorated by multiple primary cancers in esophageal cancer patients treated by radiotherapy.Three-dimensional conformal radiotherapy with concurrent chemotherapy for postoperative recurrence of esophageal squamous cell carcinoma: clinical efficacy and failure pattern Concomitant chemo-radiotherapy for unresectable oesophageal cancer: A mono-institutional study on 40 patients.Prognostic implications of FGFR1 and MYC status in esophageal squamous cell carcinoma.Metastatic squamous cell carcinoma of colon from esophageal cancer.Increased neutrophil-to-lymphocyte ratio is a novel marker for nutrition, inflammation and chemotherapy outcome in patients with locally advanced and metastatic esophageal squamous cell carcinoma.Evaluation of prognostic markers for patients with curatively resected thoracic esophageal squamous cell carcinomas.The lymphocyte-monocyte ratio predicts tumor response and survival in patients with locally advanced esophageal cancer who received definitive chemoradiotherapy.Endoscopic diagnosis and treatment of early esophageal squamous neoplasia.The role of Piccolo in cancer treatment: relationship with EGFR and related therapies, and a marker for new targeted therapies.Radiotherapy for esophageal carcinoma: dose, response and survival.Endoscopic Submucosal Dissection for Gastrointestinal Superficial Lesions: Initial Experience in a Single Portuguese Center.The Clinical Implications of Death Domain-Associated Protein (DAXX) Expression.

P2860

Q28073933-019BA4F3-E315-4ED5-9C4F-2F038A2C7064 Q33433296-35F892DB-0876-4D4F-B871-69E3302F2B04 Q33655965-E93DBF18-D7B8-4179-B6C4-4041087E7F33 Q33658207-F85B1624-7D17-487A-B576-F6495C2B554D Q33689090-8A183CCB-900D-4C3A-AEA7-C04D16C43D0E Q33710048-D180A586-14C0-430A-93EA-63AF2D09C7EE Q34176132-1CC16B56-CB7A-47E8-8997-928CFD252C14 Q35133043-5CAE8951-821B-4326-957D-6032F4B60EE1 Q35160122-386A6BBE-CD2A-4EC0-80EF-F0D843DA0FD7 Q35496579-3273E26E-B7E0-48A5-A1F9-67BF57079CA9 Q36000749-A3FE83CC-F665-402B-926E-5B1C781F94AE Q36224814-C8506857-364A-4A63-9432-B4482557980B Q37006968-251134B8-DD67-4355-9935-80837B517F76 Q37277133-C2E7A077-7C1A-42E9-8EAC-ADA5380758F2 Q37392362-740B5846-D8C5-4385-8072-345099723142 Q37444264-412A0E81-38EA-4AF7-B36B-D59900170E77 Q38827567-9B1FF074-130D-4AF6-8318-86ABC72CFC75 Q40991226-DC7175FF-BBB4-44B3-98B8-1B4E3E9BBDD3 Q41429352-C1E93F7E-530F-4508-8191-DC26D5353AB4 Q42161730-B30F11A4-6A18-4EE1-9113-CFE895511515 Q42360981-5AE30449-A4E3-466F-862B-95E641D67F72 Q47160848-8A9F83F4-D85E-40FA-80C0-076FBA155239 Q49166159-1C2ACD2C-7F32-4979-8409-4082A2F553B2 Q53067008-7A999644-A72A-4FAC-BE02-EE30FBFF53BA Q55208961-0980FEE4-B41B-43DC-9555-AB513D7C23AA

P2860

Current management of esophageal squamous-cell carcinoma in Japan and other countries.

http://www.wikidata.org/entity/Q42113341

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

2009年论文

@zh

2009年论文

@zh-cn

name

Current management of esophageal squamous-cell carcinoma in Japan and other countries.

@en

Current management of esophageal squamous-cell carcinoma in Japan and other countries.

@nl

type

label

Current management of esophageal squamous-cell carcinoma in Japan and other countries.

@en

Current management of esophageal squamous-cell carcinoma in Japan and other countries.

@nl

prefLabel

Current management of esophageal squamous-cell carcinoma in Japan and other countries.

@en

Current management of esophageal squamous-cell carcinoma in Japan and other countries.

@nl

P1433

Q42113341-81348BC6-41B2-490C-9BD0-FAFFE0E358F1

P1476

Q42113341-3D093700-FDB2-4463-B0CD-67DC36120FE2

P2093

Q42113341-08A1D4D2-5A36-4DE1-B8B5-1D81AA27D83C

Q42113341-1A4D16C2-8115-492F-B15E-DA9C94481A22

Q42113341-1AF85D38-A687-4FEB-9EEE-00614C57E10A

Q42113341-2946495D-0B2E-4E11-8BE4-CB7183A2FA66

Q42113341-44A13CD5-C87F-420C-9971-0655F4483D58

Q42113341-570EE416-02A9-40B1-81E4-2229BF333FA6

Q42113341-77E432B0-6DA7-4E6B-8A02-89DCD69709A7

Q42113341-AF16F8F6-ADDD-47D8-BD2E-C34D202D3764

Q42113341-EF440F40-C348-4796-B6A6-59EF12B51D66

Q42113341-F820E323-0D63-4B94-B86E-606E24192E19

P2860

Q42113341-011BE3FF-F878-4973-B996-6DBCF315A300

Q42113341-0158D502-933F-4B68-B8FB-B420BDF0B556

Q42113341-031E8CA5-D792-42FE-A89A-B849DB9760B9

Q42113341-0F2D05AA-3384-4178-9DD5-3B83C40B3705

Q42113341-101154B7-2409-435C-B83B-071D8780D7ED

Q42113341-2160D2CB-122F-4A2F-9314-D984EFEFE52A

Q42113341-291C335B-359A-469C-80F9-7DECDA7164DC

Q42113341-2D5B1E66-CF0C-4FF8-BAAD-9555D5A66CC6

Q42113341-317B0114-A7ED-4CDF-A2F5-4A1A09F4E3D3

Q42113341-31DDBF4A-B0EB-43AC-B8F6-4926DB361138

P304

Q42113341-A606DB14-2646-4570-B3A2-92DA38DDF598

P31

Q42113341-368060B1-A49B-41EF-9732-2AF6BFF911AE

P433

Q42113341-09AE2EBD-BE3C-46FB-841E-A2AECDB20616

P478

Q42113341-0C08D335-F527-42D6-819F-33B82EF49FA8

P577

Q42113341-FF67A8D9-0754-4F0A-82FB-B6232147ACC9

P698

Q42113341-FE8E28A8-6080-41FA-84F4-5E59B041FA68

P932

Q42113341-F328ADE1-AB36-4CBE-B43A-A16A4A3C4840

P1433

Gastrointestinal cancer research : GCR

P1476

Current management of esophageal squamous-cell carcinoma in Japan and other countries.

@en

P2093

Akira Naruke

http://www.w3.org/2001/XMLSchema#string

Chikatoshi Katada

http://www.w3.org/2001/XMLSchema#string

Katsuhiko Higuchi

http://www.w3.org/2001/XMLSchema#string

Kenji Ishido

http://www.w3.org/2001/XMLSchema#string

Kento Nakatani

http://www.w3.org/2001/XMLSchema#string

Mizutomo Azuma

http://www.w3.org/2001/XMLSchema#string

Satoshi Tanabe

http://www.w3.org/2001/XMLSchema#string

Takahiro Ryu

http://www.w3.org/2001/XMLSchema#string

Tohru Sasaki

http://www.w3.org/2001/XMLSchema#string

Wasaburo Koizumi

http://www.w3.org/2001/XMLSchema#string

P2860

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

Photodynamic therapy as salvage treatment for local failures after definitive chemoradiotherapy for esophageal cancer.

A comparison of endoscopic treatment and surgery in early esophageal cancer: an analysis of surveillance epidemiology and end results data.

[A phase II clinical study of cis-diammine glycolato platinum, 254-S, for gastrointestinal cancers. 254-S Gastrointestinal Cancer Study Group]

A phase II study of capecitabine and cisplatin (XP) as first-line chemotherapy in patients with advanced esophageal squamous cell carcinoma.

Evaluation of data quality in the cancer registry: principles and methods Part II. Completeness.

The changing epidemiology of esophageal cancer.

Genetic polymorphisms of alcohol and aldehyde dehydrogenases and risk for esophageal and head and neck cancers.

Phase II study of gemcitabine and cisplatin in locally advanced/metastatic oesophageal cancer.

Salvage oesophagectomy after local failure of definitive chemoradiotherapy.

P304

153-161

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2009-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19742141

http://www.w3.org/2001/XMLSchema#string

P932

2739640

http://www.w3.org/2001/XMLSchema#string